SCYX

SCYNEXIS INC

SCYX·811292200·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

SCYX (SCYNEXIS INC) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.4M), MILLENNIUM MANAGEMENT LLC ($570,459), GEODE CAPITAL MANAGEMENT, LLC ($446,036). Net institutional sentiment: Mixed.

25
Holders
Avg rating(5 Elite)
$3.9M
Total Value
54% (29)
Fund Consensus
13 buying - 11 selling
SCYXSmart Money Verdict
View all
Held by 25 funds
5 elite
Who's Trading
ActivistFederated Hermes, Inc.Federated Hermes, Inc.4.5%Jul 8, 2026
ActivistCICVI Investments, Inc.6.2%May 15, 2026
ActivistSMSquadron Master Fund LP9.6%Apr 8, 2026
ActivistGPGreat Point Partners, LLC10.0%Apr 7, 2026
InsiderADAngulo Gonzalez DavidBuyApr 1, 2026
ActivistKIKINGDON CAPITAL MANAGEMENT, L.L.C.0.0%Feb 17, 2026
ActivistAVAvidity Partners Management LP9.9%Feb 17, 2026
ActivistFederated Hermes, Inc.Federated Hermes, Inc.8.4%Jan 8, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.6M$1.4M0.0%+484.00%
39
New
622,161$570,4590.0%+484.00%
34
Increased
486,368(+8.3%)$446,0360.0%+15.85%
18
Decreased
332,194(-0.7%)$304,5890.0%+309.35%
0
New
225,736$207,0000.0%+484.00%
32
Increased
224,640(+27.6%)$205,9720.0%+169.95%
28
Increased
130,831(+25.9%)$119,9590.0%+585.66%
18
Unchanged
123,697$113,4180.0%+132.93%
0
Unchanged
120,730$110,6970.0%+108.67%
0
Increased
95,577(+26.7%)$87,6350.0%+128.83%
18
Increased
57,138(+283.7%)$52,3900.0%+513.88%
23
New
52,284$47,9390.0%+484.00%
28
Decreased
38,480(-19.8%)$35,2820.0%+123.12%
0
Increased
35,180(+5.3%)$32,2570.0%+411.44%
14
Decreased
28,846(-17.7%)$26,4490.0%-17.98%
0
Decreased
27,807(-45.5%)$25,4960.0%+618.03%
0
Decreased
24,868(-46.0%)$22,8020.0%+304.28%
0
Decreased
10,669(-15.6%)$9,7820.0%+352.62%
0
New
7,488$6,8660.0%+484.00%
25
Unchanged
3,100$2,8430.0%-67.58%
0

Showing 1-20 of 29

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used